Skip to main content
TXG logo

TXG · 10x Genomics, Inc. · Analyst Estimates

Track TXG — free
$51.80 -5.58 (-9.72%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$6.81B
Shares
131.53M
Volume · Nov 20 3.23M Avg daily vol (3M) 3.36M

Analyst Estimates

Compare analyst forecasts for 10x Genomics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-15 15:18 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.10
0.063
0.18
3
0.037
0.037
0.11
0.10
0
0
0
0
Revenue
USD
Publication date not stated
627.30M
631.04M
635.01M
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.01
0.087
0.20
3
0.077
0.077
0.20
0.20
0
0
0
0
Revenue
USD
Publication date not stated
663.09M
705.00M
746.50M
15
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.04
-0.04
-0.04
1
-0.005
-0.005
-0.003
-0.003
0
0
0
0
Revenue
USD
Publication date not stated
174.80M
178.64M
181.90M
13
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.03
-0.03
-0.03
1
-0.03
0.02
0.02
0.01
— —
0
1
Revenue
USD
Publication date not stated
156.88M
167.33M
180.00M
10
— — — — — — — —
Key facts CIK 1770787 CUSIP 88025U109 13F (30d) 482 filings 441 filers Visit website Investor relations